Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Native American Overdose Deaths Surge Since Opioid Epidemic

By AP | March 15, 2018

Overdose deaths in Native American communities have skyrocketed in the time the opioid epidemic has swept the U.S. and federal officials are looking for solutions.

Native Americans and Alaska Natives saw a fivefold increase in overdose deaths between 1999 and 2015, Dr. Michael Toedt told the U.S. Senate Committee on Indian Affairs on Wednesday.

Centers for Disease Control and Prevention figures indicate the increase in that period was higher for Native Americans than any other group, jumping to roughly 22 deaths for every 100,000 people in metropolitan areas and nearly 20 for every 100,000 people in non-metropolitan areas.

But the statistics, while staggering, may represent an undercount for Native Americans and Alaska Natives by as much as 35 percent, because death certificates often list them as belonging to another race, said Toedt, who is the Indian Health Services’ chief medical officer.

The hearing in Washington comes as a growing number of tribes file lawsuits against drug manufacturers and distributors, saying they misrepresented addiction risks.

Federal officials said the opioid epidemic is straining tribal resources.

U.S. Attorney John Anderson, of New Mexico, said tribal leaders in a northern stretch of the state had called for solutions. One pueblo police chief described losing a brother and sister to overdoses, he said.

“The opioid epidemic knows no boundaries,” he said, “and so our pueblos are equally affected by heroin and prescription opioids.”

Several senators questioned whether a decline in prosecutions in Indian Country cases also had contributed to the crisis.

“We need a plan and it can’t just be about treating the addiction,” said U.S. Heidi Heitkamp, D-North Dakota. “It needs to be a plan that gets law enforcement on the ground.”


Filed Under: Drug Discovery

 

Related Articles Read More >

China’s biopharma sector enters ‘innovation 2.0’ era
The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE